Xiangyang P. Chi

National Key Laboratory Of Advanced Biotechnology
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

ACE2-fused nanobody targeting a cryptic RBD epitope broadly neutralizes SARS-like viruses.

ACE2-fused nanobody targeting a cryptic RBD epitope broadly neutralizes SARS-like viruses.

Journal: Journal of virology

Published: July 30, 2026

Ultrapotent neutralization of Bacillus anthracis toxin by a human antibody via blockade of PA oligomerization.

Ultrapotent neutralization of Bacillus anthracis toxin by a human antibody via blockade of PA oligomerization.

Journal: PLoS pathogens

Published: June 03, 2026

Potent neutralization of Rift Valley fever virus mediated by monoclonal antibodies via concurrent inhibition of attachment and fusion.

Potent neutralization of Rift Valley fever virus mediated by monoclonal antibodies via concurrent inhibition of attachment and fusion.

Journal: Emerging microbes & infections

Published: February 10, 2026

Correction: Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells.

Correction: Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells.

Journal: Virology journal

Published: September 30, 2025

Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodies.

Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodies.

Journal: Virologica Sinica

Published: September 14, 2025

Bispecific antibody engineered from two non-protective antibodies confers full protection against anthrax toxin through inhibition of PA83 cleavage.

Bispecific antibody engineered from two non-protective antibodies confers full protection against anthrax toxin through inhibition of PA83 cleavage.

Journal: Microbiology spectrum

Published: August 29, 2025

Licoflavone B Suppresses Influenza A Virus by Targeting the Viral RNA-Dependent RNA Polymerase (RdRp).

Licoflavone B Suppresses Influenza A Virus by Targeting the Viral RNA-Dependent RNA Polymerase (RdRp).

Journal: Viruses

Published: July 31, 2025

Protection against lethal HAdV-4 challenge in STAT1 mice by novel human monoclonal antibodies.

Protection against lethal HAdV-4 challenge in STAT1 mice by novel human monoclonal antibodies.

Journal: Frontiers in immunology

Published: April 18, 2025

Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells.

Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells.

Journal: Virology journal

Published: March 01, 2025

Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV.

Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV.

Journal: Viruses

Published: February 25, 2025

Potent Cross-neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein.

Potent Cross-neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 01, 2025

Predicting Antibody Affinity Changes upon Mutation Based on Unbound Protein Structures.

Predicting Antibody Affinity Changes upon Mutation Based on Unbound Protein Structures.

Journal: International journal of molecular sciences

Published: January 08, 2025

Showing 1-12 of 37

Last Updated: 09/26/2026